Sylvia Wulf, CEO of the biotechnology firm, stated: “We are delighted that FDA has lifted the import alert, which will allow AquaBounty to begin producing and marketing AquAdvantage Salmon in the United States. As FDA notes in this announcement, our salmon was approved by the agency over three years ago based upon a very comprehensive science-based review process, which established that our salmon was safe, nutritious, and environmentally sound and met all other regulatory requirements. We will immediately start the process to import AquAdvantage eggs from our hatchery in Canada to begin grow out at our Indiana facility.”
Approximately 350,000 tons of Atlantic salmon is consumed in the United States with more than 95 percent of it imported.
The company has hailed the decision as "an important achievement not just for AquaBounty, but for biotechnology and agricultural innovation in general".